Clinical utility of anti-lipoarabinomannan antibodies testing for the diagnosis of tuberculous arthritis

1Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diagnosis of extrapulmonary tuberculosis (TB) is often challenging. In this work we discuss the utility of an assay for Lipoarabinomannan (LAM) antibody detection in synovial fluid. LAM is one of the three major groups of lipopolysaccharides within the Mycobacterium tuberculosis (MTB) cell wall. An ELISA based test was used to investigate the presence of antibodies against LAM in an immunocompetent patient with knee arthritis. The symptoms resolved after isoniazid treatment. LAM positivity has been used as a diagnostic tool for TB in different settings, including veterinary field. The test could be of some value to diagnose tuberculous arthritis in selected patients when gold standard test returned negative although further investigations are welcome.

Cite

CITATION STYLE

APA

Passiu, G., Erre, G. L., Pirina, P., & Sechi, L. A. (2015). Clinical utility of anti-lipoarabinomannan antibodies testing for the diagnosis of tuberculous arthritis. SpringerPlus, 4(1). https://doi.org/10.1186/s40064-015-0858-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free